Advertisement

Masthead

Articles in Press

Issue Highlights

Specialty Updates

Infectious Diseases Update: Big Data and Behavioral Economics in Infectious Disease

Ravi Jhaveri

Ravi Jhaveri, MD

Endocrinology, Diabetes, And Other Endocrine Disorders Update: To Be or Not To Be...... A Biomarker?

Uazman Alam

Uazman Alam, BSc, MPHe MRCP(UK)(London), PhD

About

Clinical Therapeutics

Cover Image - Clinical Therapeutics, Volume 43, Issue 12

Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.

Special Themed Issue on Rheumatoid Arthritis

Prevention of Rheumatoid Arthritis: Challenges and Opportunities to Change the Paradigm of Disease Management

Rheumatoid arthritis (RA) is a debilitating autoimmune disease that leads to chronic synovitis, systemic inflammation, and comorbidities which together impair quality of life and increase mortality risk. Recent advances in the understanding of RA etiology and pathogenesis suggest that prevention of RA onset in at-risk individuals may be an attainable goal. This themed issue of Clinical Therapeutics features expert perspectives on the opportunities, challenges, and progress toward development of preventive approaches for RA. Articles are accessible to all.

Novel Coronavirus Information Center

Visit the Elsevier Information Center to find the most relevant research on Novel Coronavirus (SARS-CoV-2), freely available here.

Metrics

Metrics

##
Impact Factor
##
5-Year Impact Factor
##
Eigenfactor Score

Message from the Editors

The COVID-19 pandemic has consumed global attention and caused the medical community to quickly learn how to best diagnose and manage this emerged infectious disease. These unprecedented times have resulted in efforts by the medical community to rapidly organize and publish any and all information regarding COVID-19. While the speedy dissemination of information can help clinicians around the globe potentially better manage their patients, there is also the concern that premature conclusions of efficacy or lack of efficacy may negatively influence care. Studies performed during this pandemic are uniformly falling short of our usual standard of randomized controlled trials with participants matched based on intervention and severity of illness. Overall, most journals have valued the speed to publish the most up-to-date results rather than focus on the significant flaws of these early studies.

At Clinical Therapeutics, we welcome your COVID-19 studies and want to be part of disseminating the most useful information to help clinicians around the world. However, we also want to help raise the bar on the quality of published COVID-19 research. We welcome COVID-19 studies from around the world on any aspect of the infection. While we value new findings, we are particularly interested in studies that attempt to incorporate the high standards we usually expect in clinical research.

Introducing the Editorial team

Ravi Jhaveri

Ravi Jhaveri, MD
Co-Editor-in-Chief

Dr. Ravi Jhaveri serves as the Topic Editor for the Infectious Diseases Section of Clinical Therapeutics. Dr. Jhaveri is a Professor of Pediatrics in the Division of Infectious Diseases at the Ann & Robert H. Lurie Children's Hospital of Chicago and the Northwestern University Feinberg School of Medicine. He has almost 20 years of experience as a practicing pediatric infectious disease specialist with clinical and research interests in Hepatitis C virus (HCV). His work on HCV spans through testing and treatment of infants, children and pregnant women. Dr. Jhaveri is also involved with a collaboration with former colleagues at UNC-Chapel Hill to augment screening and pre-emptive antiviral therapy with high risk Hepatitis B infected pregnant women in Africa.


Jill Maron

Jill L. Maron, MD, MPH
Co-Editor-in-Chief

Dr. Jill Maron is a Professor of Pediatrics at the Warren Alpert Medical School of Brown University. She completed her undergraduate education at Harvard University (Cambridge, MA), receiving her bachelor’s degree in Biological Anthropology cum laude. She earned both a MD and MPH degree in International Health and Development from Tulane University (New Orleans, LA) prior to completing her Pediatrics training at Hasbro Children’s Hospital at Brown University (Providence, RI). Dr. Maron completed her fellowship in Newborn Medicine at the Floating Hospital for Children at Tufts Medical Center.

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)

Advertisement